UBC PiMS Research Group (the Tremlett Laboratory)
Pharmacoepidemiology in Multiple Sclerosis Research Group (the Tremlett Laboratory)
<div class="breadcrumb breadcrumbs"><div class="breadcrumb-trail"> » <a href="https://epims.med.ubc.ca" title="UBC PiMS Research Group (the Tremlett Laboratory)" rel="home" class="trail-begin">Home</a> <span class="sep">»</span> <a href="https://epims.med.ubc.ca/our-team/" title="Our Team">Our Team</a> <span class="sep">»</span> <a href="https://epims.med.ubc.ca/our-team/fellowsandtrainees/" title="Trainees">Trainees</a> <span class="sep">»</span> Anibal Chertcoff </div></div>

Anibal Chertcoff

Academic Status: Post-Doctoral Research Fellow

Previous Academic Training: Medical Doctor at Universidad Maimonides, Buenos Aires, Argentina

Clinical Training: MS Fellowship (BARLO MS Centre, St. Michael’s Hospital, Toronto, Canada, 2022-2023; Hospital Británico de Buenos Aires, Argentina, 2018-2019), Neurology Residency (Hospital Británico de Buenos Aires, Argentina, 2014-2018), Psychiatry Residency (Hospital Alvear, Buenos Aires, Argentina, 2010-2014).

Post-Doctoral Supervisor: Helen Tremlett, PhD

Current Research Project: Psychiatric morbidity in multiple sclerosis during the prodromal period (Psych-MS)

Interviews: DMCBH Trainee Spotlight: https://www.centreforbrainhealth.ca/news/dmcbh-trainee-spotlight-dr-anibal-chertcoff/

VJNeurology profile: https://vjneurology.com/speaker/anibal-chertcoff/

 

Last updated on November 17, 2023 @5:44 pm

a place of mind, The University of British Columbia

Pharmacoepidemiology in MS (PiMS)
2211 Wesbrook Mall,
Vancouver, BC, V6T 2B5, Canada
Email:

Emergency Procedures | Accessibility | Contact UBC  | © Copyright The University of British Columbia